Heart Failure

Bodyport announced its noninvasive biomarker platform, made in the form of a scale, received FDA clearance for measurement of fluid status and heart function in patients requiring fluid management.

In patients with atrial fibrillation and concurrent HF with reduced ejection fraction, catheter ablation significantly reduced all-cause mortality compared with medical therapy, according to a new meta-analysis.

Low serum vitamin D levels were linked to left ventricular concentric remodeling and risk for HF, particularly HF with preserved ejection fraction, according to new data from the Jackson Heart Study.

Women with a history of premature menopause, defined as menopause before age 40 years, are more likely to develop HF or atrial fibrillation over 9 years of follow-up compared with women without premature menopause, data show.

Early physician follow-up with a comprehensive transitional care strategy and effective chronic disease management after discharge was associated with reduced 90-day readmissions among patients with COPD and other complex conditions.

Hypertrophic cardiomyopathy is the most common monogenic CV disorder, yet perhaps the most frequently misunderstood, and often goes undiagnosed in clinical practice.

Real-world safety and performance of the MitraClip NTR System and MitraClip XTR System (Abbott).

CVRx Inc. announced the launch of its next-generation programmer for its implantable pulse neuromodulation generator to treat HF symptoms.

The death of a close family member was associated with increased risk for death among people with HF, with risk highest during the first week after the loss, according to findings from a Swedish register-based study.

An additional $22.3 billion is spent nationally on HF-related medical services each year, with the total annual expenditure for adults with HF approaching $180 billion, according to an analysis of Medical Expenditure Panel Survey data.